Home
Contact
✕
Lung cancer
Home
Lung cancer
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
Uncategorized
All
Adolescents and young adults
Anal cancer
Antioxidants
Blood cancers
Breast cancer
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
Communication
COVID-19
De-escalation
Esophagus cancer
GI cancer
Green tea
Head and neck cancer
Health equity
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Language
Late Effects
Leukemia
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Mesothelioma
Minimal residual disease
MRI
Multiple myeloma
Myeloma
NCI-MATCH
Neuropathy
Older adults
Pancreatic cancer
Pancreatic cysts
Patient-reported outcomes
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Squamous cell carcinoma
Surveillance
Survivorship
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Diane Dragaud
ecogacrinnews2
Katie Heller
June 24, 2021
June 24, 2021
Categories
Trial Results
Trial Results: ECOG-ACRIN Research Round-Up – Spring 2021
Summaries of recently reported ECOG-ACRIN research results
September 20, 2021
September 20, 2021
Categories
Trial Results
Trial Results: Recent ECOG-ACRIN research
Summaries of recently reported ECOG-ACRIN research results
September 20, 2021
September 20, 2021
Categories
Editorials
The Language of (Lung) Cancer
A new language guide encourages respect, eliminates blame, and promotes health equity
December 15, 2021
December 15, 2021
Categories
Ongoing Trials
Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread
This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation